{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T06:06:34Z","timestamp":1789452394655,"version":"build-2803163510"},"reference-count":11,"publisher":"Jaypee Brothers Medical Publishing","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.59556\/japi.74.1689","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:53:02Z","timestamp":1789451582000},"page":"58-62","source":"Crossref","is-referenced-by-count":0,"title":["Safety and Effectiveness of Cyclosporine and Eltrombopag in Acquired Aplastic Anemia: Experience from a Tertiary Care Center in Eastern India"],"prefix":"10.59556","volume":"74","author":[{"given":"Shuvraneel","family":"Baul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaustav","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhra Kamal","family":"Saha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuphan Kanti","family":"Dolai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2914","reference":[{"issue":"(17):","key":"key20260915055255_B1","doi-asserted-by":"crossref","first-page":"1643\u2013","DOI":"10.1056\/NEJMra1413485","article-title":"Aplastic anemia.","volume":"379","author":"Young","year":"2018;","journal-title":"N Engl J Med"},{"issue":"(2):","key":"key20260915055255_B2","doi-asserted-by":"crossref","first-page":"126\u2013","DOI":"10.5045\/kjh.2012.47.2.126","article-title":"Should we still use Camitta's criteria for severe aplastic anemia?","volume":"47","author":"Yoon","year":"2012;","journal-title":"Korean J Hematol"},{"issue":"(3):","key":"key20260915055255_B3","doi-asserted-by":"crossref","first-page":"357\u2013","DOI":"10.1007\/s12288-022-01592-4","article-title":"Idiopathic aplastic anemia: Indian perspective.","volume":"39","author":"Dolai","year":"2023;","journal-title":"Indian J Hematol Blood Transfus"},{"issue":"(11):","key":"key20260915055255_B4","doi-asserted-by":"crossref","first-page":"1428\u2013","DOI":"10.1182\/blood-2016-08-693481","article-title":"How I treat acquired aplastic anemia.","volume":"129","author":"Bacigalupo","year":"2017;","journal-title":"Blood"},{"issue":"(3):","key":"key20260915055255_B5","doi-asserted-by":"crossref","first-page":"784\u2013","DOI":"10.1111\/bjh.19236","article-title":"Guidelines for the diagnosis and management of adult aplastic anaemia: a British Society for Haematology guideline.","volume":"204","author":"Kulasekararaj","year":"2024;","journal-title":"Br J Haematol"},{"issue":"(1):","key":"key20260915055255_B6","doi-asserted-by":"crossref","first-page":"11\u2013","DOI":"10.1056\/NEJMoa2109965","article-title":"Eltrombopag added to immunosuppression in severe aplastic anemia.","volume":"386","author":"Peffault de Latour","year":"2022;","journal-title":"N Engl J Med"},{"key":"key20260915055255_B7","volume-title":"Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0.","author":"U.S. Department of Health and Human Services.","year":"2017."},{"issue":"(3):","key":"key20260915055255_B8","doi-asserted-by":"crossref","first-page":"e206\u2013","DOI":"10.1016\/S2352-3026(23)00395-2","article-title":"Activity and safety of eltrombopag in combination with cyclosporin A as first line treatment of adults with severe aplastic anaemia (SOAR): a phase 2, single-arm study.","volume":"11","author":"Scheinberg","year":"2024;","journal-title":"Lancet Haematol"},{"issue":"(3):","key":"key20260915055255_B9","doi-asserted-by":"crossref","first-page":"407\u2013","DOI":"10.1111\/ejh.14021","article-title":"Cyclosporine plus eltrombopag in the treatment of aplastic anemia with or without antithymocyte immunoglobulin: a multicenter real-world retrospective study.","volume":"111","author":"Chen","year":"2023;","journal-title":"Eur J Haematol"},{"issue":"(16):","key":"key20260915055255_B10","doi-asserted-by":"crossref","first-page":"1540\u2013","DOI":"10.1056\/NEJMoa1613878","article-title":"Eltrombopag added to standard immunosuppression for aplastic anemia.","volume":"376","author":"Townsley","year":"2017;","journal-title":"N Engl J Med"},{"issue":"(4):","key":"key20260915055255_B11","doi-asserted-by":"crossref","first-page":"584\u2013","DOI":"10.1002\/ajh.27611","article-title":"Elderly patients with aplastic anemia: treatment patterns and outcomes in the real world.","volume":"100","author":"Fattizzo","year":"2025;","journal-title":"Am J Hematol"}],"container-title":["Journal of The Association of Physicians of India"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T05:53:04Z","timestamp":1789451584000},"score":1,"resource":{"primary":{"URL":"https:\/\/japi.org\/article\/japi-74-9-58"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":11,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.59556\/japi.74.1689"],"URL":"https:\/\/doi.org\/10.59556\/japi.74.1689","relation":{},"ISSN":["0004-5772"],"issn-type":[{"value":"0004-5772","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]}}}